everything in mobile is still growing.UsersHandsetsDataPurchasesAdvertisingTime spent on appsEVERYTHING IS INCREASING!Companies have only scratched the surface of the revenue potential
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress